Early autologous stem cell transplantation in poor-risk chronic lymphocytic leukaemia. Long-term results from the GCLLSG CLL3 trial focusing on incidence and type of secondary malignancies

被引：0
|
作者：
McClanahan, F. [1 ]
Stilgenbauer, S. [2 ]
Greinix, H. [3 ]
Hensel, M. [4 ]
Hertenstein, B. [5 ]
Duehrsen, U. [6 ]
Hentrich, M. [7 ]
Truemper, L. [8 ]
Sonnen, R.
Emmerich, B. [9 ]
Knauf, W. [10 ]
Hopfinger, G. [3 ]
Hallek, M. [11 ]
Kneba, M. [12 ]
Schmitz, N.
Doehner, H. [2 ]
Dreger, P. [1 ]
机构：
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] Univ Hosp Ulm, Ulm, Germany
[3] Univ Hosp Vienna, Vienna, Austria
[4] Mannheimer Onkolol Praxis, Mannheim, Germany
[5] Klinikum Bremen Mitte, Bremen, Germany
[6] Univ Hosp Essen, Essen, Germany
[7] Stadt Klinikum Munchen, Munich, Germany
[8] Univ Hosp Gottingen, Gottingen, Germany
[9] Tumorzentrum Munchen, Munich, Germany
[10] Onkol Gemeinschaftspraxis, Frankfurt, Germany
[11] Univ Hosp Cologne, Cologne, Germany
[12] Univ Hosp Kiel, Kiel, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S41 / S42
页数：2
相关论文
共 41 条
  • [31] Improved Long-Term Survival after Myeloablative Chemotherapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma Patients. Results of the NB97 Trial
    Simon, T.
    Hero, B.
    Ruth, V.
    Angelika, E.
    Frank, B.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 : S39 - S39
  • [32] Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry
    Ana Jiménez-Ubieto
    Carlos Grande
    Dolores Caballero
    Lucrecia Yáñez
    Miguel Teodoro Hernández-Garcia
    Silvana Novelli
    Reyes Arranz
    José Javier Ferreiro
    Sabella Bobillo
    Santiago Mercadal
    Andrea Galeo
    Javier López Jiménez
    José María Moraleda
    Carlos Vallejo
    Carmen Albo
    Elena Pérez
    Carmen Marrero
    Laura Magnano
    Luis Palomera
    Isidro Jarque
    Pilar Martínez-Sánchez
    Alejandro Martín
    Erika Coria
    Armando López-Guillermo
    Antonio Salar
    Juan José Lahuerta
    [J]. Bone Marrow Transplantation, 2018, 53 : 780 - 783
  • [33] Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry
    Jimenez-Ubieto, Ana
    Grande, Carlos
    Caballero, Dolores
    Yanez, Lucrecia
    Teodoro Hernandez-Garcia, Miguel
    Novelli, Silvana
    Arranz, Reyes
    Javier Ferreiro, Jose
    Bobillo, Sabella
    Mercadal, Santiago
    Galeo, Andrea
    Lopez Jimenez, Javier
    Maria Moraleda, Jose
    Vallejo, Carlos
    Albo, Carmen
    Perez, Elena
    Marrero, Carmen
    Magnano, Laura
    Palomera, Luis
    Jarque, Isidro
    Martinez-Sanchez, Pilar
    Martin, Alejandro
    Coria, Erika
    Lopez-Guillermo, Armando
    Salar, Antonio
    Jose Lahuerta, Juan
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (06) : 780 - 783
  • [34] Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial
    Mai, Elias K.
    Benner, Axel
    Bertsch, Uta
    Brossart, Peter
    Haenel, Annette
    Kunzmann, Volker
    Naumann, Ralph
    Neben, Kai
    Egerer, Gerlinde
    Ho, Anthony D.
    Hillengass, Jens
    Raab, Marc S.
    Neubauer, Andreas
    Peyn, Astrid
    Ko, Yon-Dschun
    Peter, Norma
    Scheid, Christof
    Goldschmidt, Hartmut
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (05) : 731 - 741
  • [35] Long-term survival in patients suffering from AML with a complex aberrant karyotype after early allogeneic stem cell transplantation using the FLAMSA-RIC regimen: results from a prospective phase II trial
    Schmid, C.
    Schleuning, M.
    Tischer, J.
    Hahn, J.
    Baurmann, H.
    Schwerdtfeger, R.
    Ledderose, G.
    Lallinger, C.
    Franke, A.
    Cook, A.
    Holler, E.
    Hiddemann, W.
    Kolb, H. J.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S75 - S75
  • [36] Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients
    Michallet, Mauricette
    Sobh, Mohamad
    Deloire, Alexandre
    Revesz, Daniela
    Chelgoum, Youcef
    El-Hamri, Mohamed
    Barraco, Fiorenza
    Labussiere-Wallet, Helene
    Nicolini, Franck Emmanuel
    Hequet, Olivier
    [J]. BLOOD, 2017, 130
  • [37] Long-term results of risk-adapted salvage treatment with single or tandem autologous stem cell transplantation for first-relapse/refractory Hodgkin's lymphoma: results of the prospective multicentre H96 trial by the GELA/SFGM-TC Study Group
    Sibon, D.
    Resche-Rigon, M.
    Bouabdallah, R.
    Morschhauser, F.
    Ferme, C.
    Gaillard, I.
    Salles, G.
    Sebban, C.
    Brice, P.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S45 - S45
  • [38] High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: Long-term results of a randomized control trial from the group myelome-autogreffe
    Fermand, J
    Katsahian, S
    Divine, M
    Leblond, V
    Dreyfus, F
    Macro, M
    Arnulf, B
    Royer, B
    Mariette, X
    Pertuiset, E
    Belanger, C
    Janvier, M
    Chevret, S
    Brouet, JC
    Ravaud, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9227 - 9233
  • [39] Conditioning with Busulfan Plus Melphalan (Bu-Mel) Results in More Prolonged Progression-Free Survival (PFS) Versus Melphalan (Mel) Alone before Autologous Stem Cell Transplantation (auto-HCT) in Patients with High-Risk Multiple Myeloma (MM): Long-Term Results of a Randomized, Phase 3 Trial
    Bashir, Qaiser
    Thall, Peter
    Milton, Denai R.
    Kawedia, Jitesh D.
    Kebriaei, Partow
    Patel, Krina
    Andersson, Bode S.
    Nieto, Yago
    Valdez, Ben C.
    Parmar, Simrit M. D.
    Rondon, Gabriela
    Delgado, Ruby
    Hosing, Chitra M.
    Popat, Uday R.
    Oran, Betul
    Ciurea, Stefan O.
    Lin, Pei
    Weber, Donna
    Thomas, Sheeba
    Lee, Hans C.
    Manasanch, Elisabet
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Williams, Loretta
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S241 - S242
  • [40] Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study
    Bonifazi, Francesca
    Solano, Carlos
    Wolschke, Christine
    Sessa, Mariarosaria
    Patriarca, Francesca
    Zallio, Francesco
    Nagler, Arnon
    Selleri, Carmine
    Risitano, Antonio Maria
    Messina, Giuseppe
    Bethge, Wolfgang
    Herrera, Pilar
    Sureda, Anna
    Carella, Angelo Michele
    Cimminiello, Michele
    Guidi, Stefano
    Finke, Juergen
    Sorasio, Roberto
    Ferra, Christelle
    Sierra, Jorge
    Russo, Domenico
    Benedetti, Edoardo
    Milone, Giuseppe
    Benedetti, Fabio
    Heinzelmann, Marion
    Pastore, Domenico
    Jurado, Manuel
    Terruzzi, Elisabetta
    Narni, Franco
    Voelp, Andreas
    Ayuk, Francis
    Ruutu, Tapani
    Kroeger, Nicolaus
    [J]. LANCET HAEMATOLOGY, 2019, 6 (02): : E89 - E99
12345